on behalf of the TOTAL Investigators

Slides:



Advertisements
Similar presentations
The EMERALD Trial Diabetic Substudy. EMERALD Diabetic Analysis To compare myocardial perfusion and infarct sizes in diabetic and non-diabetic patients.
Advertisements

Distal Protection: PRIDE, CAPTIVE Symbiot III, AiMI Dr James Cotton MD MRCP Heart and Lung Centre Wolverhampton.
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Can we prevent stent restenosis after coronary stent implantation
Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial David.
Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial David.
Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy. PRAGUE 13 trial O.
TOTAL Culprit lesion thrombus burden after manual aspiration thrombectomy or PCI alone in STEMI The OCT Substudy of the TOTAL (ThrOmbecTomy versus PCI.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients Bruce Brodie, Adam Bensimhon, Nathan Fleishman, Charles Hansen, Mike Cooper,
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
The AiMI Trial Arshad Ali, MD, David Cox, MD, Nabil Dib, MD, Bruce Brodie, MD, Daniel Berman, MD, Navin Gupta, MD, Kevin Browne, MD, Robert Iwaoka, MD,
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
Results of CRYSTAL AMI: A Pilot Trial Before INFUSE AMI, the Concept and Evolution in Thrombus Management Saihari Sadanandan, MD, FACC, FASE, Dip. CBNC,
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
G.SARDELLA Dip.di SCIENZE CARDIOVASCOLARI POLICLINICO UMBERTO I GENNARO SARDELLA, MD, FACC,FESC O.U. of Invasive Cardiology, Dept. of Cardiovascular Sciences.
ACS and Thrombosis in the Emergency Setting
Proxis Proximal embolic protection in saphenous vein graft and infarct PCI Dan Blackman Leeds General Infirmary Advanced Angioplasty 2006.
Presentation at a Non PCI Facility Requiring Transfer Does NOT Worsen Long-term Prognosis in Patients With STEMI Undergoing Primary Angioplasty. The HORIZONS-AMI.
Richard Melsheimer Director, Medical Affairs Europe Centocor Eli Lilly and Company Coordinated Use of ReoPro and Drug Eluting Stents: Rationale and Evidence.
ATTEMPT study: pooled-Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data CLINICAL TRIAL UPDATE III ESC.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.
The Impact of Thrombus Aspiration on 1-year Mortality in Primary PCI for ST-Elevation Myocardial Infarction, ACSIS 2010 Experience Mady Moriel, Shlomi.
on behalf of the TOTAL Investigators
RESEARCH, REDUCE III, X-AMINE ST, COOL-MI Azfar Zaman Freeman Hospital, Newcastle.
The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented.
A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction.
Disclosure Statement of Financial Interest
For OMA distribution only. Trademarks may be registered and are the property of their respective owners. © 2013 Medtronic, Inc. All rights reserved. UC ML.
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Trial Vignettes 1-3 Mark Mason Harefield Hospital Royal Brompton and Harefield NHS Trust.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
MUSTELA : A Prospective, Randomized Trial of Thrombectomy vs. no Thrombectomy in Patients with ST-Segment Elevation Myocardial Infarction and Thrombus-Rich.
The MASTER Trial A Prospective, Randomized, Multicenter Evaluation of a PET Micronet Mesh Covered Stent (MGuard) in STEMI Sigmund Silber, MD, PhD FESC,
↓ 30 d mortality ↓ Distal embolization ↑ Myocardial Blush 3 ↑TIMI 3 Post De Luca et al. EHJ 2008;29:
The SAFER Trial Evaluation of the Clinical Safety and Efficacy of the PercuSurge GuardWire in Saphenous Vein Graft Intervention As presented at TCT 2000.
Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) Trial Presented at The American College of Cardiology Scientific Session.
Treatment of Thrombotic Lesions Ramesh Daggubati, MD FACC FSCAI Director of Interventional Cardiology East Carolina University Greenville, NC USA.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
Rationale for TOTAL trial: randomized trial of routine aspiration ThrOmbecTomy with PCI vs. PCI ALone in patients with STEMI undergoing primary PCI Sanjit.
Is the Debate Over? Routine Thrombus Aspiration in STEMI (From TAPAS to INFUSE-AMI to TASTE to TOTAL) Stefan James Professor of Cardiology Uppsala Clinical.
Is There a Role for Aspiration in STEMI?
Thomas Stiermaier, MD; Suzanne de Waha, MD;
Valsartan in Acute Myocardial Infarction Trial Investigators
Circ Cardiovasc Interv
European Society of Cardiology 2003
Dr. PJ Devereaux on behalf of POISE Investigators
Modified Rankin score 0-2
The HORIZONS-AMI Trial
A Systematic Review and Meta-analysis of Randomized Trials of Manual Thrombectomy in ST elevation myocardial infarction Investigators: Ashraf Alazzoni,
Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:
Dr. PJ Devereaux on behalf of POISE Investigators
TAXUS – Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable Jeffrey J. Popma,
Mancini JG, et al. Am J Cardiol.
What oral antiplatelet therapy would you choose?
Dye strongly persistent
DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
IVUS-XPL Trial design: Patients undergoing drug-eluting stent implantation for long coronary lesions were randomized to IVUS-guided PCI (n = 700) vs. angiography-guided.
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
Section C: Clinical trial update: Oral antiplatelet therapy
Presentation transcript:

on behalf of the TOTAL Investigators Angiographic Sub-study of the TOTAL trial: a randomized trial of manual thrombectomy during PCI for STEMI CB Overgaard, V Sharma, T Hameed, D Sharma, J Chiha, W Chan, F Fuchs, S Kassam, R Leung, D Horak, H Romppanen, M El Omar, S Chowdhary, G Stankovic, S Kedev, M Rokoss, T Sheth, , V Džavík, SS Jolly on behalf of the TOTAL Investigators

Disclosures TOTAL trial was funded by: Canadian Institutes of Health Research Canadian Network and Centre for Trials Internationally (CANNeCTIN) Medtronic Inc.

Background Myocardial blush grade has been shown to predict mortality after primary percutaneous coronary intervention (PPCI)1 Small trials have shown improvement in myocardial blush grade with manual thrombectomy2 Van 't Hof AW et al Circulation 1998; 97(23):2302-2306 Svilaas T et al NEJM 2008; 358 (96): 557-567 Svilaas T et al. N Engl J Med 2008;358:557-567.

Background The TOTAL trial is an international, prospective randomized (multicenter) trial of manual thrombus aspiration (using the Export® catheter, Medtronic CardioVascular, Santa Rosa, CA) in STEMI patients versus PPCI alone TOTAL demonstrated no benefit to routine aspiration in patients undergoing PPCI for STEMI

Study Questions Does manual thrombectomy compared to PCI Alone impact: Myocardial blush grade 0/1 Final TIMI flow Distal embolization and other Angiographic complications Are these angiographic outcomes associated with mortality?

The TOTAL Trial Study Design STEMI* with Primary PCI ≤12 hours of symptom onset Sample size of 10,700 for 80% power to detect a 20% Relative Risk Reduction 1:1 Randomization between strategies Routine Upfront Manual Thrombectomy followed by PCI PCI Alone (only bailout thrombectomy) Primary Outcome: CV death, MI, cardiogenic shock and class IV heart failure ≤180 days Safety Outcome: Stroke ≤30 days Bailout Thrombectomy allowed if PCI alone strategy fails: Persistent TIMI 0 or 1 flow with large thrombus after balloon pre-dilatation Persistent large thrombus after stent deployment at target lesion

Methods The sub-study randomly selected 1610 patients from the TOTAL cohort (80% power to detect 25% RR reduction MBG 0 or 1 for manual thrombectomy) Angiographic parameters were blinded to treatment assignment at the angiographic core lab (Peter Munk Cardiac Centre, Toronto, Canada)

Primary Outcome Thrombectomy PCI alone p value   Thrombectomy (N=791) (%) PCI alone (N=819) (%) p value Myocardial Blush Grade 0,1 221 (28%) 246 (30%) 0.38 Myocardial Blush Grade 2,3 567 (72%) 573 (70%) Post PCI TIMI Flow 0 9 (1.1%) 6 (0.7%) 0.4 Post PCI TIMI Flow 1 11 (1.4%) 10 (1.2%) 0.76 Post PCI TIMI Flow 2 59(7.5%) 70 (8.5%) 0.42 Post PCI TIMI Flow 3 712 (90%) 733 (89.5%) 0.73

Secondary Outcomes Thrombectomy PCI alone p value Distal Embolization   Thrombectomy (N=791) (%) PCI alone (N=819) (%) p value Distal Embolization 56 (7.1%) 87 (10.7%) 0.01 Abrupt IRA Closure 7 (0.9%) 1 (0.1%) 0.02 PPCI Complications 94 (11.9%) 126 (15.5%) 0.04 Perforation 4 (0.5%) 5 (0.6%) 0.78 Dissection 26 (3.3%) 22 (2.7%) 0.48 IRA Sidebranch Closure 9 (1.1%) 0.66 Thrombus Formation 6 (0.8%) 6 (0.7%) 0.95 Transient No-reflow 14 (1.8%) 11 (1.3) 0.49 Left Main Dissection 0 (0 %) -

Subgroup Analysis for MBG 0/1

Myocardial Blush Grade and Mortality HR 2.84 (95%CI 1.23-6.54) P=0.01

Distal Embolization and Mortality HR 3.63 (95%CI 1.77-7.46) P=0.01

Independent Predictors of Mortality 0.25 0.50 1.00 2.00 4.00 8.00 Thrombectomy vs PCI Age per 10 years Symptom Onset to device per 30 minutes MBG 0/1 vs 2/3 Killip class SBP Heart Rate Weight <67 kg Distal embolization HR(95%CI) 0.46 (0.18-1.13) 1.35 (0.95-1.91) 1.01 (1.00-1.03) 2.23 (0.94-5.3) 2.73 (1.00-7.49) 0.98 (0.97-1) 1.03 (1.02-1.05) 3.26 (1.35-7.87) 3.00 (1.19-7.58)

Conclusions Routine thrombectomy did not result in an improvement in final myocardial blush or TIMI Flow following PPCI for STEMI Routine thrombectomy reduced angiographic distal embolization Distal embolization was independently associated with mortality in multivariable analysis while myocardial blush was not